[go: up one dir, main page]

HK1012342A1 - Tricyclic pyrazole derivatives - Google Patents

Tricyclic pyrazole derivatives Download PDF

Info

Publication number
HK1012342A1
HK1012342A1 HK98113447A HK98113447A HK1012342A1 HK 1012342 A1 HK1012342 A1 HK 1012342A1 HK 98113447 A HK98113447 A HK 98113447A HK 98113447 A HK98113447 A HK 98113447A HK 1012342 A1 HK1012342 A1 HK 1012342A1
Authority
HK
Hong Kong
Prior art keywords
methyl
disorders
dihydro
pyrazol
methoxy
Prior art date
Application number
HK98113447A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1012342B (en
Inventor
Wichmann Jurgen
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of HK1012342A1 publication Critical patent/HK1012342A1/xx
Publication of HK1012342B publication Critical patent/HK1012342B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
HK98113447.5A 1994-08-12 1998-12-15 Tricyclic pyrazole derivatives HK1012342B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2490/94 1994-08-12
CH249094 1994-08-12

Publications (2)

Publication Number Publication Date
HK1012342A1 true HK1012342A1 (en) 1999-07-30
HK1012342B HK1012342B (en) 2002-06-28

Family

ID=

Also Published As

Publication number Publication date
DK0700905T3 (da) 2002-02-18
PT700905E (pt) 2002-04-29
NO953162L (no) 1996-02-13
MA23643A1 (fr) 1996-04-01
ZA956553B (en) 1996-02-12
FI953827L (fi) 1996-02-13
KR960007568A (ko) 1996-03-22
AU2838295A (en) 1996-02-22
PL182480B1 (pl) 2002-01-31
BR9503630A (pt) 1996-05-28
ES2164730T3 (es) 2002-03-01
FI113264B (fi) 2004-03-31
NZ272731A (en) 1996-09-25
EP0700905A1 (de) 1996-03-13
HUT72066A (en) 1996-03-28
PL309974A1 (en) 1996-02-19
JPH0859623A (ja) 1996-03-05
RU2152388C1 (ru) 2000-07-10
JP2755560B2 (ja) 1998-05-20
IL114849A0 (en) 1995-12-08
ATE207905T1 (de) 2001-11-15
NO953162D0 (no) 1995-08-11
CN1056607C (zh) 2000-09-20
KR100385384B1 (ko) 2003-09-19
IL114849A (en) 1999-11-30
CA2153937C (en) 2007-04-10
AU691310B2 (en) 1998-05-14
MY133619A (en) 2007-11-30
NO305026B1 (no) 1999-03-22
CZ9502013A3 (en) 1996-03-13
DE59509777D1 (de) 2001-12-06
UY24016A1 (es) 2000-12-29
TR199500977A2 (tr) 1996-06-21
CN1131666A (zh) 1996-09-25
FI953827A0 (fi) 1995-08-11
TW403738B (en) 2000-09-01
CA2153937A1 (en) 1996-02-13
PE34096A1 (es) 1996-10-04
PH31424A (en) 1998-10-29
CO4410331A1 (es) 1997-01-09
EP0700905B1 (de) 2001-10-31
US5561150A (en) 1996-10-01
CZ289027B6 (cs) 2001-10-17

Similar Documents

Publication Publication Date Title
US5561150A (en) Tricyclic pyrazole derivatives
DE60014370T2 (de) Substituierte heterocyclylkondensierte gamma carboline
DE60002554T2 (de) Pyrazino(aza)indolderivate
EP0657426B1 (de) Tricyclische Pyrrol-Derivate
US7592454B2 (en) Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
AU596206B2 (en) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-hydro-5h- 2,3- benzodiazepine acid addition salts thereof and process for preparing same
EP0485636A1 (en) Indole derivative
EP0269968A2 (de) Heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU2020363354A1 (en) Aryl heterobicyclic compounds as Kv1.3 potassium shaker channel blockers
EP0361791B1 (en) Azacyclic derivatives useful as medicaments
US4424226A (en) Pyridobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof
WO2002059082A2 (en) Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
BG99253A (en) Epi - epibatydine derivatives
HK1012342B (en) Tricyclic pyrazole derivatives
US4123545A (en) N-Propyl-3(β-hydroxyethyl)-3-(meta-hydroxyphenyl)-pyrrolidine
JPS6043068B2 (ja) アゼピノ〔1,2,3−1m〕−β−カルボリン誘導体及びその製法
EP0447704A1 (en) N-Acylated azacyclic compounds, processes for their preparations and their use as medications
FR2722501A1 (fr) Derives de 9h-imidazo(1,2-a)benzimidazole-3-acetamide, leur preparation et leur application en therapeutique
JPH07503256A (ja) フェニルイミダゾリジノン誘導体およびその製造法
PIERSON IBOGA ALKALOID SYNTHESIS, BENZAZEPINE APPROACH
FR2700544A1 (fr) Dérivés de 9H-imidazo[1,2-a]benzimidazole-3-acétamide, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050804